Grants

PI Name PI Organization Title Grant Number Initiative Program Director
Hitchins, Megan P

Cedars-Sinai Medical Center
United States

 Discovery and verification of methylated circulating tumor DNA markers for the detection of colorectal cancer in subjects under 50 years of age 5R01CA252042-02 PA-20-185 (Parent R01 Clinical Trial Not Allowed) Matthew Young, Ph.D.
Hollingsworth, Michael A.

University Of Nebraska Medical Center
United States

 Pancreatic Cancer Detection Consortium 2U01CA210240-06 PAR-21-334 (U01 Clinical Trial Optional) Sharmistha Ghosh-Janjigian, Ph.D.
Hollingsworth, Michael A.

University Of Nebraska Medical Center
United States

 Pancreatic Cancer Detection Consortium 2U01CA210240-06 PAR-21-334 (U01 Clinical Trial Optional) Sharmistha Ghosh-Janjigian, Ph.D.
Houghton, A Mcgarry

Fred Hutchinson Cancer Center
United States

 Tumor-specific autoantibodies for SCLC early detection 5R01CA243328-05 Lynn Sorbara, Ph.D.
Hur, Chin

Columbia University Health Sciences
United States

 Optimal Colorectal Cancer Surveillance Strategy for Lynch Syndrome by Genotype 5R01CA257333-02 PA-20-185 (Parent R01 Clinical Trial Not Allowed) Matthew Young, Ph.D.
Iagaru, Andrei

Stanford University
United States

 Molecular Imaging Methods for the Detection of Pancreatic Ductal Adenocarcinoma 5U01CA210020-05 Guillermo Marquez, Ph.D.
Ibsen, Stuart Duncan

Oregon Health & Science University
United States

 Distinguishing Pancreatic Cancer from Benign Pancreatic Disease using Nanoparticle-based Biomarkers 5R37CA258787-02 PAR-20-053 (R01 Clinical Trial Not Allowed) Matthew Young, Ph.D.
Ivanov, Alexander R.

Northeastern University
United States

 Effect of methodological and biological variability on molecular profiling of extracellular vesicles in cancer detection 3R01CA218500-05S1 Matthew Young, Ph.D.
Iyer, Prasad G.

Mayo Clinic Rochester
United States

 Minimally Invasive Molecular Approaches for the Detection of Barrett’s Esophagus and Esophageal Adenocarcinoma 5R01CA241164-04 Matthew Young, Ph.D.
Jiang, Feng

University Of Maryland Baltimore
United States

 Plasma biomarkers for lung cancer diagnosis 5UH2CA251139-02 PAR-18-317 Lynn Sorbara, Ph.D.